未找到相关数据
Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
被引：0
作者：
Chen, Yueyun
Ding, Zhen-Yu
Yuan, Yong
Yang, Yu-Shang
Lin, Zhen
Tian, Jiangfang
Liu, Ting
Yue, Zheng
Shi, Hua-Shan
Hu, Yang
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Peoples R China
关键词：
283-424-6846-271-2644;
261-492-5651-2790;
613-4678-146;
613-135-244-3829;
281-318-430;
261-492-2769;
261-566-148-2649;
6;
4;
3;
2;
3342;
2414;
38092-34417;
1;
D O I：
10.1200/JCO.2024.42.3_suppl.352
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352 / 352
页数：1
相关论文